Elevance Health (NYSE:ELV) Has More To Do To Multiply In Value Going Forward
Sector Update: Health Care Stocks Higher Friday Afternoon
Update: DOJ Sues Medicare Insurers Over Alleged Kickback Scheme
Truist Financial Maintains Elevance Health(ELV.US) With Buy Rating, Maintains Target Price $510
Here's How Much $1000 Invested In Elevance Health 20 Years Ago Would Be Worth Today
Shares Fall for Some Insurance Companies, Brokers Named in DOJ Complaint
Aetna, Humana Accused of Discrimination in Medicare Advantage Plan Enrollment
The USA has filed a fraudulent claim lawsuit against three Medical Insurance companies.
The USA Department of Justice announced on Thursday that it has filed a lawsuit against the three largest Medical Insurance companies in the USA, Aetna Inc. and its affiliates Elevance Health and Humana, for violations of the False Claims Act. Reportedly, this lawsuit also affects three large Insurance Institutions: eHealth, GoHealth, and SelectQuote. In its press release, the Department stated, "Government agencies allege that from 2016 to at least 2021, the defendant insurance companies paid hundreds of millions of dollars in illegal kickbacks to the defendant brokers in exchange for these brokers' Medical...
DOJ Files Complaint Against Aetna, EHealth, Others, Alleging Medicare Advantage Kickbacks
Express News | U.S. Alleges Aetna And Humana Each Conspired With Broker Defendants To Discriminate Against Medicare Beneficiaries With Disabilities; U.S Alleges Defendant Insurers Paid Hundreds Of Millions Of Dollars In Illegal Kickbacks To The Defendant Brokers- DOJ
Elevance Health Insiders Sell US$6.9m Of Stock, Possibly Signalling Caution
Elevance Health (ELV) Gets a Buy From Truist Financial
Elevance Health, Inc. (ELV): Among the Best Stocks to Buy According to D1 Capital's Daniel Sundheim
New Analyst Forecast: $ELV Given $465.0 Price Target
Is Elevance (ELV) an Attractively Valued Stock?
Top Executive Sells Millions in Elevance Health Stock!
Argus Research Maintains Elevance Health(ELV.US) With Buy Rating, Raises Target Price to $465
Trump Likes Concept of Millionaire Tax, Would Veto Medicaid Cuts - Report
A Quick Look at Today's Ratings for Elevance Health(ELV.US), With a Forecast Between $478 to $585
'Medicaid to the Rescue,' Says Wall St. Analyst About Elevance Health (ELV) Stock